Similar articles

• Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.

  Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S, Hartmann G. Kerkmann M, et al. J Immunol. 2003 May 1;170(9):4465-74. doi: 10.4049/jimmunol.170.9.4465. J Immunol. 2003. PMID: 12707322
• Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-alpha.

  Heyder P, Bekeredjian-Ding I, Parcina M, Blank N, Ho AD, Herrmann M, Lorenz HM, Heeg K, Schiller M. Heyder P, et al. Autoimmunity. 2007 Jun;40(4):331-2. doi: 10.1080/08916930701356515. Autoimmunity. 2007. PMID: 17516221 No abstract available.
• Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells.

  Mazzoni A, Leifer CA, Mullen GE, Kennedy MN, Klinman DM, Segal DM. Mazzoni A, et al. J Immunol. 2003 Mar 1;170(5):2269-73. doi: 10.4049/jimmunol.170.5.2269. J Immunol. 2003. PMID: 12594246
• Human and mouse plasmacytoid dendritic cells.

  Hochrein H, O'Keeffe M, Wagner H. Hochrein H, et al. Hum Immunol. 2002 Dec;63(12):1103-10. doi: 10.1016/s0198-8859(02)00748-6. Hum Immunol. 2002. PMID: 12480253 Review.
• Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications.

  Guiducci C, Coffman RL, Barrat FJ. Guiducci C, et al. J Intern Med. 2009 Jan;265(1):43-57. doi: 10.1111/j.1365-2796.2008.02050.x. J Intern Med. 2009. PMID: 19093959 Review.